An announcement made by the U.S. Department of State-President’s Emergency Plan for AIDS Relief (PEPFAR) to bring U.S.-based Gilead Sciences’ breakthrough drug lenacapavir to market in high-burden HIV countries has excited the National AIDS Commission-(NAC) saying it is a sigh of relief to most affected countries including Malawi. The PEPFAR support is expected to reach...
Category: News
Post
NAC JOINS LAUNCH OF FOUR STRATEGIC GENDER DOCUMENTS
The Ministry of Gender, Community Development and Social Welfare has launched four strategic documents aimed at providing a strong policy framework on gender programing in the country. The strategic documents are the Ministry of Gender, Community Development and Social Welfare Strategic Plan (2024–2030), National Gender Policy (2025–2030), National Integrated Early Childhood Development Policy (ECD), and...
Post
THE MALAWI HIV AND AIDS PARTNERSHIP FORUM (MPF) MEMBERS GATHERED IN LILONGWE TO DISCUSS TOPICAL ISSUES ON NATIONAL RESPONSE TO HIV AND AIDS
The 71st meeting of the Malawi HIV and AIDS Partnership Forum (MPF) was held on August 20th, 2024, in the Malawi Capital city Lilongwe. The meeting ended on a high note with the incoming MPF members pledging a commitment to work collaboratively to generate domestic funding. The MPF is an advisory body to the National...
Post
From Relief to Resilience! NAC Advocates for Sustainable, African-Focused Health Systems
At the Africa’s Roadmap to Self-Reliant Healthcare Webinar on August 27, 2025, Dr. Beatrice Matanje, CEO of the National AIDS Commission, delivered a compelling call to action below: The path ahead is not paved with aid but with audacity. Africa has the talent, resolve, and ingenuity to build health systems that serve our people. Let’s...
Post
NATIONAL AIDS COMMISSION HOLDS HIGH-LEVEL MEDIA ENGAGEMENT TO SHARE LATEST INFORMATION ON HIV AND AIDS AND ADDRESS MEDIA CONCERNS
In its quest to improve working relationship with the media, the National AIDS Commission (NAC) on Tuesday August 22, 2025, organized a day-long high-level media engagement. The meeting was held in Mponera. The Commission observed that media interaction was one fundamental aspect to leveraging cordial working relationships as it takes lead in the multisectoral coordination...
Post
NAC CALLS FOR MULTISECTORAL UNITY IN MOBILIZING DOMESTIC FINANCING OF THE NATIONAL HIV AND AIDS RESPONSE
Let’s join hands to mobilize domestic funding towards national response to HIV and AIDS programming amidst dwindling global resources for external financing. The National AIDS Commission Chief executive officer Dr. Beatrice Matanje made the call on Tuesday 19th August 2025, during orientation of executive members of the Malawi HIV and AIDS Partnership Forum (MPF). Dr....
Post
Exciting News! Malawi hits the 95:95:95 HIV Targets ahead of the Deadline
Exciting news to share! Over the years, Malawi has registered remarkable strides in the fight against HIV and AIDS since the first case was reported in 1985. NAC Chief executive Officer, Dr. Beatrice Matanje has attributed this to strong political will, community leadership, and the unwavering support of partners. Dr. Matanje proudly mentioned that Malawi...
Post
Malawi Leverages South-to-South Learning Network to Reimagine HIV Prevention
Malawi’s HIV prevention champions have gathered at the Bingu International Convention Centre (BICC) in Lilongwe from July 17–18, 2025 to chart new pathways for HIV prevention amidst declining financial resources. The meeting, supported by the South-to-South Learning Network (SSLN), also focuses on advancing the use of the HIV Prevention Programme Planning Tool(3PT) Since joining the...
Post
The Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low-and Middle-Income Countries.
Malawi National AIDS Commissions joins global experts in describing this as a pivotal moment on the road to ending AIDS as a public health threat— ensuring lifesaving innovation reaches those who need it most, wherever they live. The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed...
Post
HIV Long term injectable drug approved! The National AIDS Commission appeals for continued adherence to present PrEP.
Exciting news! The United States Food and Drug Administration (FDA) has approved an injectable drug for HIV prevention called Lenacapavir (LEN) as Pre-Exposure Prophylaxis. The drug needs to be injected just twice a year for the HIV Negative at-risk population groups. The approval means the drug could be rolled out globally to help overcome barriers...